N-acetylcysteine reduces chemokine release via inhibition of p38 MAPK in human airway smooth muscle cells

European Respiratory Journal

Volumn 22, Issue 1, 2003, Pages 43-49

  Wuyts, W A ^a   Vanaudenaerde, B M ^a   Dupont, L J ^a   Demedts, M G ^a   Verleden, Geert M ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Human airway smooth muscle cells; Interleukin 1 ; N acetylcysteine; Oxidative stress; p38 mitogen activated protein kinase; Signal transduction

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; CHEMOKINE; EOTAXIN; INTERLEUKIN 1BETA; ISOPROSTANE; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; REACTIVE OXYGEN METABOLITE;

ARTICLE; ASTHMA; BREATHING MUSCLE; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG EFFECT; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER;

EID: 0042812457     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.03.00064803     Document Type: Article

References (35)

1. Busse WW, Lemanske RF Jr. Asthma. N Engl J Med 2001; 344: 350 362.
2. Wills-Karp M. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu Rev Immunol 1999; 17: 255-281.
3. Pype JL, Dupont LJ, Menten P, et al. Expression of monocyte chemotactic protein (MCP)-1, MCP-2, and MCP-3 by human airway smooth-muscle cells. Modulation by corticosteroids and T-helper 2 cytokines. Am J Respir Cell Mol Biol 1999; 21: 528-536.
4. Wuyts WA, Pype JL, Verleden GM. Modulation of IL-1β-induced MCP-1, MCP-3 and eotaxin expression in human airway smooth muscle cells. Am J Respir Crit Care Med 2001; 161: A594.
5. Dworski R, Roberts LJ, Murray JJ, Morrow JD, Hartert TV, Sheller JR. Assessment of oxidant stress in allergic asthma by measurement of the major urinary metabolite of F2-isoprostane, 15-F2t-IsoP (8-iso-PGF2alpha). Clin Exp Allergy 2001; 31: 387-390.
6. Montuschi P, Corradi M, Ciabattoni G, Nightingale J, Kharitonov SA, Barnes PJ. Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients. Am J Respir Crit Care Med 1999; 160: 216-220.
7. Schreck R, Rieber P, Baeuerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J 1991; 10: 2247 2258.
8. Wilmer WA, Tan LC, Dickerson JA, Danne M, Rovin BH. Interleukin-1 beta induction of mitogen-activated protein kinases in human mesangial cells. Role of oxidation. J Biol Chem 1997; 272: 10877-10881.
9. Schreck R, Albermann K, Baeuerle PA. Nuclear factor kappa B: an oxidative stress-responsive transcription factor of eukaryotic cells. Free Radic Res Commun 1992; 17: 221-237.
10. Schieven GL, Kirihara JM, Myers DE, Ledbetter JA, Uckun FM. Reactive oxygen intermediates activate NF-kappa B in a tyrosine kinase-dependent mechanism and in combination with vanadate activate the p561ck and p59fyn tyrosine kinases in human lymphocytes. Blood 1993; 82: 1212-1220.
11. Moriguchi T, Toyoshima F, Gotoh Y, et al. Purification and identification of a major activator for p38 from osmotically shocked cells. Activation of mitogen-activated protein kinase kinase 6 by osmotic shock, tumor necrosis factor-alpha, and H2O2. J Biol Chem 1996; 271: 26981-26988.
12. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
13. Pype JL, Xu H, Schuermans M, et al. Mechanisms of interleukin 1 beta-induced human airway smooth muscle hyporesponsiveness to histamine. Involvement of p38 MAPK and NF-kappaB. Am J Respir Crit Care Med 2001; 163: 1010-1017.
14. Hashimoto S, Gon Y, Matsumoto K, Takeshita I, Horie T. N-acetylcysteine attenuates TNF-alpha-induced p38 MAP kinase activation and p38 MAP kinase-mediated IL-8 production by human pulmonary vascular endothelial cells. Br J Pharmacol 2001; 132: 270-276.
15. Sato M, Miyazaki T, Nagaya T, et al. Antioxidants inhibit tumor necrosis factor-alpha mediated stimulation of interleukin-8, monocyte chemoattractant protein-1, and collagenase expression in cultured human synovial cells. J Rheumatol 1996; 23: 432-438.
16. Rincon M. MAP-kinase signaling pathways in T cells. Curr Opin Immunol 2001; 13: 339-345.
17. Kujime K, Hashimoto S, Gon Y, Shimizu K, Horie T. p38 mitogen-activated protein kinase and c-jun-NH2-terminal kinase regulate RANTES production by influenza virus-infected human bronchial epithelial cells. J Immunol 2000; 164: 3222-3228.
18. Hashimoto S, Gon Y, Takeshita I, et al. Diesel exhaust particles activate p38 MAP kinase to produce interleukin 8 and RANTES by human bronchial epithelial cells and N-acetylcysteine attenuates p38 MAP kinase activation. Am J Respir Crit Care Med 2000; 161: 280-285.
19. Calhoun WJ, Reed HE, Moest DR, Stevens CA. Enhanced superoxide production by alveolar macrophages and air-space cells, airway inflammation, and alveolar macrophage density changes after segmental antigen bronchoprovocation in allergic subjects. Am Rev Respir Dis 1992; 145: 317-325.
20. Jarjour NN, Busse WW, Calhoun WJ. Enhanced production of oxygen radicals in nocturnal asthma. AM Rev Respir Dis 1992; 146: 905-911.
21. Bascom R, Bromberg P, Costa D. Health effects of outdoor air pollution. Am J Respir Crit Care Med 1996; 153: 3-50.
22. Dworski R. Oxidant stress in asthma. Thorax 2000; 55: Suppl. 2, S51-S53.
23. Rochelle LG, Fischer BM, Adler KB. Concurrent production of reactive oxygen and nitrogen species by airway epithelial cells in vitro. Free Radic Biol Med 1998; 24: 863-868.
24. Sen CK. Redox signaling and the emerging therapeutic potential of thiol antioxidants. Biochem Pharmacol 1998; 55: 1747 1758.
25. Chan ED, Riches DW, White CW. Redox paradox: effect of N-acetylcysteine and serum on oxidation reduction-sensitive mitogen-activated protein kinase signaling pathways. Am J Respir Cell Mol Biol 2001; 24: 627-632.
26. Rao GN, Katki KA, Madamanchi NR, Wu Y, Birrer MJ. JunB forms the majority of the AP-1 complex and is a target for redox regulation by receptor tyrosine kinase and G protein-coupled receptor agonists in smooth muscle cells. J Biol Chem 1999; 274: 6003-6010.
27. Clerk A, Fuller SJ, Michael A, Sugden PH. Stimulation of "stress-regulated" mitogen-activated protein kinases (stress-activated protein kinases/c-Jun N-terminal kinases and p38-mitogen-activated protein kinases) in perfused rat hearts by oxidative and other stresses. J Biol Chem 1998; 273: 7228-7234.
28. Dworski R, Murray JJ, Roberts LJ, et al. Allergen-induced synthesis of F(2)-isoprostanes in atopic asthmatics. Evidence for oxidant stress. Am J Respir Crit Care Med 1999; 160: 1947-1951.
29. Gillissen A, Nowak D. Characterization of N-acetylcysteine and ambroxol in anti-oxidant therapy. Respir Med 1998; 92: 609-623.
30. Berggren M, Dawson J, Moldeus P. Glutathione biosynthesis in the isolated perfused rat lung: utilization of extracellular glutathione. FEBS Lett 1984; 176: 189-192.
31. Aruoma OI, Halliwell B, Hoey BM, Butler J. The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radic Biol Med 1989; 6: 593-597.
32. Bernard GR. Potential of N-acetylcysteine as treatment for the adult respiratory distress syndrome. Eur Respir J 1990; 3: Suppl. 11, 496s-498s.
33. Suter PM, Domenighetti G, Schaller MD, et al. N-acetylcysteine enhances recovery from acute lung injury in man. A randomized, double-blind, placebo-controlled clinical study. Chest 1994; 105: 190-194.
34. van Zandwijk N. N-acetylcysteine (NAC) and glutathione (GSH): antioxidant and chemopreventive properties, with special reference to lung cancer. J Cell Biochem Suppl 1995; 22: 24-32.
35. Schmidt LE, Dalhoff K. Risk factors in the development of adverse reactions to N-acetylcysteine in patients with paracetamol poisoning. Br J Clin Pharmacol 2001; 5187-91.